Offline Exhibitions

where we are

We are thrilled to announce our participation in hubXchange’s Boston Oligonucleotide Therapeutics 2024, where we will be presenting a keynote session titled "mRNA Technology Challenge and Process Scheme." This session is poised to be a focal point of the event's overarching theme: addressing and finding solutions to the key issues faced in oligonucleotide therapeutics.

Key Learning Objective

●  Current status of mRNA therapeutic drugs

● mRNA therapeutic drug process development challenges and solutions

● Vazyme's work in mRNA raw materials and process innovation

Presenters Biography

Tianqi Min

Product Director

A seasoned professional with a diverse background in biotechnology and marketing. Since 2020, he has been an integral part of Vazyme, contributing significantly to the establishment of the single B cell antibody screening platform and the development of mRNA raw material products. Recognized for his expertise and dedication, he was appointed Product Director for the mRNA raw materials product line in 2023. With a blend of scientific knowledge and strategic marketing skills, he plays a pivotal role in shaping the company's growth and market positioning.

HubXchange was created in response to feedback from executives attending conferences who bemoaned the inadequate opportunities to engage and network with peers at their level. With more than 20 years of experience in the conference sector across the Life Sciences and other markets, hubXchange is well-placed to respond to this need and offer a unique and high-level platform for executives to engage and network with each other.